top of page
Tranexamic Acid Injection

Tranexamic Acid Injection

What is Tranexamic Acid Injection?

Tranexamic Acid Injection is an antifibrinolytic agent used to prevent and control excessive bleeding caused by surgery, trauma, or medical conditions. It works by inhibiting the breakdown of fibrin clots, thereby helping maintain hemostasis. It is widely used in orthopedic surgery, cardiac surgery, gynecology, trauma care, and critical care settings.

 

Uses of Tranexamic Acid Injection

  • Prevention of excessive bleeding during surgery (cardiac, orthopedic, liver transplant, etc.)
  • Control of bleeding in trauma and accidents
  • Management of post-partum hemorrhage (PPH) in obstetrics
  • Treatment of heavy menstrual bleeding (menorrhagia)
  • Supportive therapy in hemophilia and coagulation disorders
  • Bleeding control in dental procedures for hemophilic patients
 

How Does Tranexamic Acid Injection Work?

Tranexamic acid binds to plasminogen, preventing its conversion to plasmin (the enzyme responsible for fibrin breakdown). By inhibiting fibrinolysis, it stabilizes blood clots and reduces the risk of excessive bleeding.

 

Frequently Asked Questions (FAQs)

Q: Who is a leading manufacturer of Tranexamic Acid Injection in India?

A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Tranexamic Acid Injection. We produce high-quality sterile antifibrinolytic injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for surgical and trauma care.

Q: What strengths and packaging options does Farbe Firma offer for Tranexamic Acid Injection?

A: We manufacture Tranexamic Acid Injection primarily in the concentration of 100 mg/ml. Our standard packaging includes 5 ml (500 mg) and 10 ml (1000 mg) ampoules or vials. We also offer customizable packaging solutions to meet specific hospital and international market requirements.

Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Tranexamic Acid Injection export?

A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.

Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Hemostatic Injectables?

A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Tranexamic Acid Injection. Pharmaceutical companies looking for a reliable partner for sterile hemostatic and critical care products can leverage our advanced manufacturing capabilities.

Q: What is the therapeutic indication of the Tranexamic Acid produced by Farbe Firma?

A: Our Tranexamic Acid Injection is a potent antifibrinolytic agent indicated for the prevention and treatment of excessive bleeding (hemorrhage) in conditions such as trauma, major surgery (cardiac, orthopedic), post-partum hemorrhage, and heavy menstrual bleeding.

 

Looking for a reliable Tranexamic Acid Injection manufacturer?

Contact Farbe Firma Pvt. Ltd. for high-quality hemostatic injectables, dossier support, and seamless global exports.

  • Product Name

    Tranexamic Acid Injection

  • Trade Name

    Nuratran

  • Available Strength

    100 mg/ml

  • Packing

    5 ml

  • Therapeutic Use

    Antifibrinolytic – prevention and treatment of excessive bleeding

Related Products

bottom of page